About Singular Genomics
Singular Genomics is a company based in San Diego (United States) founded in 2016 by Eli Glezer was acquired by Deerfield in December 2024. The company has 169 employees as of June 30, 2021. Singular Genomics offers products and services including G4X Platform and Sequencing Support Hub. Singular Genomics operates in a competitive market with competitors including Nanopore, PacBio, Omniome, Complete Genomics and GenapSys, among others.
- Headquarter San Diego, United States
- Employees 169 as on 30 Jun, 2021
- Founders Eli Glezer
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Singular Genomics Systems, Inc.
-
Annual Revenue
$2.91 M (USD)281as on Dec 31, 2023
-
Net Profit
-$94.82 M (USD)-4as on Dec 31, 2023
-
EBITDA
-$102.8 M (USD)-10as on Dec 31, 2023
-
Latest Funding Round
Not available
-
Investors
Casdin Capital
& 1 more
-
Employee Count
169
as on Jun 30, 2021
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Singular Genomics
Singular Genomics offers a comprehensive portfolio of products and services, including G4X Platform and Sequencing Support Hub.
High-throughput system for in situ multiomics analysis of biological samples.
Resources for users of G4X platform in genomics research.
People of Singular Genomics
Unlock access to complete
Unlock access to complete
Funding Insights of Singular Genomics
Detailed funding history for Singular Genomics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Singular Genomics
Singular Genomics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Casdin Capital and Deerfield.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Locked | Locked | Locked | |
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Locked | Locked | Locked |
Investor details for Singular Genomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Singular Genomics
Investment portfolio details for Singular Genomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Singular Genomics
Detailed financials for Singular Genomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Singular Genomics Comparisons
Peer comparison for Singular Genomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Singular Genomics
Singular Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nanopore, PacBio, Omniome, Complete Genomics and GenapSys, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Nanopore-based electronic systems for single-molecule analysis are developed.
|
|
| Locked | Locked | Locked |
Instrument systems and software for single-molecule real-time sequencing are developed.
|
|
| Locked | Locked | Locked |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| Locked | Locked | Locked |
DNA sequencing platform for human genome analysis is developed.
|
|
| Locked | Locked | Locked |
Provider of DNA sequencing technologies for applied genomic testing and medical sequencing
|
|
| Locked | Locked | Locked |
DNA-encoded libraries are developed for drug discovery applications.
|
Detailed competitors of Singular Genomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Singular Genomics
Complete news archive for Singular Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Singular Genomics
Singular Genomics was founded in 2016.
Singular Genomics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
As of Jun 30, 2021, the latest employee count at Singular Genomics is 169.
Annual revenue of Singular Genomics is $2.91M as on Dec 31, 2023.
Singular Genomics was founded in 2016 in San Diego, United States, within the biotechnology sector focused on genomics. Next-generation sequencing and multi-omics technologies are developed and offered through integrated solutions. The G4 solution targets next-generation sequencing applications, while the PX solution addresses single-cell analysis, spatial profiling, and proteomics needs. Operations emphasize innovative engines for diverse research and diagnostic uses in life sciences.
Singular Genomics's top competitors include Nanopore, PacBio and Novogene Corporation.
Singular Genomics offers G4X Platform and Sequencing Support Hub.
Singular Genomics has 2 investors. Key investors include Casdin Capital, and Deerfield.